BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 23721372)

  • 1. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.
    Bera E; McCausland K; Nonkwelo R; Mgudlwa B; Chacko S; Majeke B
    AIDS; 2010 Jan; 24(2):283-9. PubMed ID: 19864931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
    AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
    Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating HIV during pregnancy: an update on safety issues.
    Watts DH
    Drug Saf; 2006; 29(6):467-90. PubMed ID: 16752931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry.
    Brown RS; Verna EC; Pereira MR; Tilson HH; Aguilar C; Leu CS; Buti M; Fagan EA
    J Hepatol; 2012 Nov; 57(5):953-9. PubMed ID: 22766470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
    Ford N; Mofenson L; Shubber Z; Calmy A; Andrieux-Meyer I; Vitoria M; Shaffer N; Renaud F
    AIDS; 2014 Mar; 28 Suppl 2():S123-31. PubMed ID: 24849471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.
    Townsend CL; Willey BA; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2009 Feb; 23(4):519-24. PubMed ID: 19165088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contraindicated drugs.
    Floridia M; Tamburrini E; Ravizza M; Anzidei G; Tibaldi C; Bucceri A; Maccabruni A; Guaraldi G; Meloni A; Ravagni Probizer MF; Guerrao B; Martinelli P;
    Antivir Ther; 2006; 11(7):941-6. PubMed ID: 17302258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
    Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
    Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry.
    Vannappagari V; Albano JD; Koram N; Tilson H; Scheuerle AE; Napier MD
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():6-10. PubMed ID: 26687320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multicohort Analysis.
    Martinez de Tejada B; Gayet-Ageron A; Winterfeld U; Thorne C; Favarato G;
    J Acquir Immune Defic Syndr; 2019 Mar; 80(3):316-324. PubMed ID: 30570524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
    French CE; Tookey PA; Cortina-Borja M; de Ruiter A; Townsend CL; Thorne C
    Antivir Ther; 2013; 18(2):183-92. PubMed ID: 23475123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.